Pharmaceuticals News

Combines Osivax's proprietary OVX836 T-cell vaccine and technology with GC Biopharma's marketed influenza vaccine and worldwide manufacturing expertisePositions Osivax as the global development lead...

CLINUVEL PHARMACEUTICALS LTD announced its tenth consecutive annual profit and further rise in free cash in the financial year ended 30 June 2026 (FY2026).

Press Release Nicox Announces April 2027 PDUFA Date for NCX 470 in Glaucoma FDA sets Prescription Drug User Fee Act (PDUFA) review response date by 30 April 2027Two NDAs filed in major markets, with...

Communiqué de presseNicox annonce avril 2027 comme date PDUFA pour NCX 470 dans le traitement du glaucome La FDA a fixé la date de réponse à l’examen de la NDA dans le cadre du Prescription Drug User...

Junshi Biosciences announced its 2026 interim financial results and provided corporate updates.

RYONCIL Market Share Expands; Phase 3 Back Pain Trial Completes Treatment Financial Results and Operational Update for Full Year Ended June 30, 2026 NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) --...

LOUISVILLE, Ky., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, is grateful to be selected as a pharmacy partner by Revolution Medicines for...

Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients

SAN DIEGO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways...

European Patent Office granted Vaxart a new patent, extending intellectual property protection for Vaxart’s Norovirus vaccine program through at least 2036 across key European marketsKEY HIGHLIGHTS:•...